EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation

The recommendation is for prevention of stroke and systemic embolism in atrial fibrillation and for the treatment and prevention of DVT and PE.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news